HIF1A and hepatocellular carcinoma: Under hypoxic conditions, the activation of hypoxia-inducible factor-1 alpha (HIF-1α) promotes EMT in hepatocellular carcinoma (HCC) and induces drug resistance by increasing P-glycoprotein (Multidrug Resistance 1; MDR1) expression.